27% growth in prescriptions dispensed over prior quarter; 147% growth over comparable quarter in 2022. 5 consecutive quarters of double-digit growth. Click here to learn more ›

Melanocortin Agonist PL9643 Significantly Improves Ocular Signs and Symptoms of Moderate to Severe Dry Eye Disease, Including Tear Film Break Up Time

Scroll to Top